Abstract
IntroductionImatinib is a tyrosine kinase inhibitor (TKI) widely used in the treatment of chronic myeloid leukaemia and other malignancies in which tyrosine kinases are over expressed. The first case of...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have